Meghan B Skiba1,2, Paula B Luis3, Chelsea Alfafara1, Dean Billheimer2,4, Claus Schneider3, Janet L Funk1. 1. College of Medicine, Department of Medicine, University of Arizona, Tucson, 85724, AZ, USA. 2. Mel and Enid Zuckerman College of Public Health, Department of Health Promotion Sciences, University of Arizona, Tucson, 85724, AZ, USA. 3. School of Medicine, Department of Pharmacology, Vanderbilt University, Nashville, 37232, TN, USA. 4. Mel and Enid Zuckerman College of Public Health, Department of Epidemiology and Biostatistics.
Abstract
SCOPE: Turmeric is a top selling dietary supplement (DS) in the United States with rapidly expanding usage. Therefore, turmeric DS formulations available for sale in an urban US retail marketplace are analyzed, and point of sale information is related to measures of quality relevant to safety. METHODS AND RESULTS: Eighty-seven unique turmeric DS are identified; a majority (94%) contained turmeric-derived curcuminoid extracts (TD-CE), which are combined with other bioactives in 47% of products, including piperine (24%), an additive that could alter the metabolism of concurrent medications. While curcuminoid content is within 80% of anticipated for a majority of products analyzed (n = 35), curcuminoid composition (% curcumin) did not meet US Pharmacopeia (USP) criteria for TD-CE in 59% and is suggestive of possible unlabeled use of synthetic curcumin in some. Lead content is associated with the inclusion of turmeric root and exceeded USP limits in one product. Residues of toxic class 1 or 2 solvents, which are not needed for TD-CE isolation, are present in 71% of products, although quantified levels were within USP-specified limits. CONCLUSION: Assessment of turmeric DS quality at point of sale is difficult for consumers and may best be managed in partnership with knowledgeable healthcare professionals.
SCOPE: Turmeric is a top selling dietary supplement (DS) in the United States with rapidly expanding usage. Therefore, turmeric DS formulations available for sale in an urban US retail marketplace are analyzed, and point of sale information is related to measures of quality relevant to safety. METHODS AND RESULTS: Eighty-seven unique turmeric DS are identified; a majority (94%) contained turmeric-derived curcuminoid extracts (TD-CE), which are combined with other bioactives in 47% of products, including piperine (24%), an additive that could alter the metabolism of concurrent medications. While curcuminoid content is within 80% of anticipated for a majority of products analyzed (n = 35), curcuminoid composition (% curcumin) did not meet US Pharmacopeia (USP) criteria for TD-CE in 59% and is suggestive of possible unlabeled use of synthetic curcumin in some. Lead content is associated with the inclusion of turmeric root and exceeded USP limits in one product. Residues of toxic class 1 or 2 solvents, which are not needed for TD-CE isolation, are present in 71% of products, although quantified levels were within USP-specified limits. CONCLUSION: Assessment of turmeric DS quality at point of sale is difficult for consumers and may best be managed in partnership with knowledgeable healthcare professionals.
Authors: Janet L Funk; Janice N Oyarzo; Jennifer B Frye; Guanjie Chen; R Clark Lantz; Shivanand D Jolad; Aniko M Sólyom; Barbara N Timmermann Journal: J Nat Prod Date: 2006-03 Impact factor: 4.050
Authors: Aynun N Begum; Mychica R Jones; Giselle P Lim; Takashi Morihara; Peter Kim; Dennis D Heath; Cheryl L Rock; Mila A Pruitt; Fusheng Yang; Beverly Hudspeth; Shuxin Hu; Kym F Faull; Bruce Teter; Greg M Cole; Sally A Frautschy Journal: J Pharmacol Exp Ther Date: 2008-04-16 Impact factor: 4.030
Authors: John Cuomo; Giovanni Appendino; Adam S Dern; Erik Schneider; Toni P McKinnon; Mark J Brown; Stefano Togni; Brian M Dixon Journal: J Nat Prod Date: 2011-03-17 Impact factor: 4.050
Authors: Odaine N Gordon; Paula B Luis; Rachel E Ashley; Neil Osheroff; Claus Schneider Journal: Chem Res Toxicol Date: 2015-04-03 Impact factor: 3.739
Authors: Andrew G Kunihiro; Paula B Luis; Jennifer B Frye; Wade Chew; H H Chow; Claus Schneider; Janet L Funk Journal: Mol Nutr Food Res Date: 2020-06-25 Impact factor: 5.914
Authors: Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Julia N Cheng; Paula B Luis; Claus Schneider; Janet L Funk Journal: J Nutr Biochem Date: 2021-08-15 Impact factor: 6.048
Authors: Seon Beom Kim; Jonathan Bisson; J Brent Friesen; Luca Bucchini; Stefan Gafner; David C Lankin; Shao-Nong Chen; Guido F Pauli; James B McAlpine Journal: J Nat Prod Date: 2021-03-12 Impact factor: 4.050